key: cord-0737437-6ru36mpj
authors: Lee, Yeong Yeh; Bredenoord, Albert J.; Gyawali, C. Prakash
title: RECOMMENDATIONS FOR ESSENTIAL ESOPHAGEAL PHYSIOLOGICTESTING DURING THE COVID-19 PANDEMIC
date: 2020-05-03
journal: Clin Gastroenterol Hepatol
DOI: 10.1016/j.cgh.2020.04.075
sha: 31c667ad970b9bd925b4d276e54544c7bd16bcfa
doc_id: 737437
cord_uid: 6ru36mpj

nan

The first human case of novel coronavirus disease 2019 (COVID-19), caused by SARS-COV-2, was reported in Wuhan, China in December 2019 1 . As of April 17 2020, the World Health Organization (WHO) estimates that more than 2 million people are infected in 184 countries around the globe, with 145,000 deaths, with the United States currently most affected. In this unprecedented COVID-19 pandemic, routine clinical services are severely disrupted, with as much health care personnel and resources as possible deployed to the frontlines.

As countries, regions and cities have imposed lockdown measures, gastrointestinal motility laboratories have been ordered by hospital authorities to 'close' their services for an indeterminate period of time. Esophageal physiologic testing is among the many clinical procedures that are considered 'non-emergent', since high resolution manometry (HRM), pH and pH-impedance studies are performed for non-life threatening indications. Many physicians, including the authors, are struggling with patients who suffer from refractory undiagnosed gastrointestinal symptoms, who could benefit from esophageal physiologic testing to triage management. How are gastroenterologists managing esophageal symptoms to function under these extra-ordinary circumstances? Clearly, accepted indications for esophageal physiologic testing 2 3 cannot be implemented since guidelines for social distancing impact elective interactions between patients and healthcare providers. In the absence of guidance regarding emergent indications for esophageal physiologic testing in the COVID-19 era, we have developed practical guidelines for triaging patients for safe performance of some of these tests, in settings where management decisions could be expedited to relieve patient symptoms and prevent complications, while simultaneously shortening hospital stay.

Aerosolizing procedures in settings where the patient's infectious status is unknown can impact health care providers performing aerodigestive and gastrointestinal procedures 4 .

While endotracheal intubation, bronchoscopy and upper endoscopy are anticipated to aerosolize the most, one can anticipate that nasal intubation of manometry and pH/pH impedance catheters will generate coughing, retching and aerosolization. While there is no conclusive evidence that endoscopy and esophageal physiologic testing transmit viruses such as SARS-CoV-2 5 , these procedures are being severely limited out of an abundance of caution in absence of evidence to the contrary. However, some patients with esophageal symptoms may have obstructive motor disease needing urgent management, while others may be regurgitating in the context of severe reflux and pulmonary disease; both are at risk for aspiration. In modern healthcare systems where clinical practice needs exist in a continuum, there is often difficulty in separating what is elective from what is emergent. We have developed a scheme for identifying patients at highest risk for adverse consequences if esophageal physiologic testing is not performed, those that need testing within weeks and cannot wait months, and others that have purely elective indications (Table 1) . These recommendations could be useful in triaging patients during the current lockdown, but will also be useful in prioritizing testing on the backlog of patients once clinical activities resume.

We emphasize that the alternatives offered are not equivalent to the optimal physiologic test indicated, e.g. barium esophagogram may overlook spastic achalasia, in contrast to HRM.

The use of the listed inferior alternatives should therefore always be balanced against delaying the diagnostic esophageal physiologic test until this can be safely performed.

Before considering even emergent or urgent motility testing during the pandemic, it is essential to establish that operating procedures in the motility laboratory ensure safe practice for both patients and staff. The SARS-CoV-2 virus remains viable in aerosols for hours and on surfaces for days, but is easily killed due to its porous lipid shell 6 Procedure rooms should be cleaned and disinfected regularly before and after routine use.

Reusable laboratory inventory such as HRM catheters should be promptly cleaned and disinfected after use as per manufacturer recommendations and institution guidelines. All disposable items (e.g. pH/pH-impedance catheters) should not be reused and must be promptly and safely disposed after the procedure.

Personal protective equipment (PPE) similar to that recommended for upper endoscopy is reasonable for esophageal physiologic testing 10 . While this may vary by region, appropriate PPE consists at least of a fluid repellent surgical or N95 mask, full arm-length disposable apron, eye-protection and non-sterile single or double gloves for patients not suspected to have COVID-19, but recommendations have potential to change as insights into disease spread further develop 11 . Esophageal manometry should not be performed in highly suspect symptomatic or COVID-19 positive patients. Both donning and doffing of PPE should be carried out in a proper manner 4 . Optimally, only one staff member interact with the patient and perform the procedure. Prior to nasal intubation, additional protective measures may be applicable including the use of virucidal povidone-iodine 7% gargle or mouthwash 7 .

After the procedure, the procedure area should be thoroughly cleaned and disinfected before the next patient is brought in. limited available data related to endoscopy, interpreted within the framework of the authors' experience. While we have not specifically discussed anorectal motility studies, these recommendations would also apply, especially since fecal transmission remains a risk 8 . As the acute crisis resolves and motility laboratories open back up for business, we suggest that emergent/urgent procedures are given priority, followed by semi-urgent procedures, and finally elective procedures. Of course, how and when reopening will occur remains unknown, and must be adapted to the local context. We hope more detailed recommendations will become available in the near future from respective specialty societies to guide practitioners not just during but also following the pandemic. 

Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study

British Society of Gastroenterology guidelines for oesophageal manometry and oesophageal reflux monitoring

Practice guidelines on the use of esophageal manometry -A GISMAD-SIGE-AIGO medical position statement

COVID-19) outbreak: what the department of endoscopy should know

Low risk of covid-19 transmission in GI endoscopy

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Evidence for Gastrointestinal Infection of SARS-CoV-2

COVID-19: Gastrointestinal Manifestations and Potential Fecal-Oral Transmission

Global Surveillance for human infection with coronavirus disease (COVID-19). Interim Guid

AGA Institute Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic

Endoscopy units and the COVID-19 Outbreak: A Multi-Center Experience from Italy